{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:25:29Z","timestamp":1765758329112,"version":"3.30.1"},"reference-count":26,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.3201\/eid1808.111202","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T18:29:29Z","timestamp":1373912969000},"page":"1290-1297","source":"Crossref","is-referenced-by-count":41,"title":["Factors Related to Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobial Drugs in<i>Neisseria gonorrhoeae<\/i>, United States"],"prefix":"10.3201","volume":"18","author":[{"given":"Edward","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Kirkcaldy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reshef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillard","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pardis","family":"Sabeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward W.","family":"Hook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Lipsitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid1808.111202-201307151429-R1","unstructured":"Centers for Disease Control and Prevention. Gonococcal Isolate Surveillance Project annual report. 2007 [cited 2012 May 22]. http:\/\/www.cdc.gov\/std\/gisp2007\/GISPSurvSupp2007Complete.pdf"},{"key":"key-10.3201\/eid1808.111202-201307151429-R2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/00007435-199808000-00011","article-title":"Gonorrhea in the United States, 1981\u20131996. Demographic and geographic trends.","volume":"25","author":"Fox","year":"1998","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid1808.111202-201307151429-R3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/14656560902731993","article-title":"The use of cephalosporins for gonorrhea: the impending problem of resistance.","volume":"10","author":"Barry","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.3201\/eid1808.111202-201307151429-R4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.7326\/0003-4819-148-8-200804150-00005","article-title":"Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies.","volume":"148","author":"Workowski","year":"2008","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1808.111202-201307151429-R5","first-page":"1","article-title":"1993 sexually transmitted diseases treatment guidelines.","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1808.111202-201307151429-R6","article-title":"Increase of gonococcal quinolone resistance in the Netherlands from 2002\u20132004.","volume":"10","author":"Borgen","year":"2005","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid1808.111202-201307151429-R7","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/S0140-6736(03)13489-7","article-title":"Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.","volume":"361","author":"Fenton","year":"2003","journal-title":"Lancet"},{"key":"key-10.3201\/eid1808.111202-201307151429-R8","first-page":"1041","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001.","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1808.111202-201307151429-R9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/jac\/dkm434","article-title":"Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997\u20132006.","volume":"61","author":"Tapsall","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1808.111202-201307151429-R10","first-page":"332","article-title":"Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1808.111202-201307151429-R11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/QCO.0b013e328320a836","article-title":"Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.","volume":"22","author":"Tapsall","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.3201\/eid1808.111202-201307151429-R12","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1086\/511422","article-title":"Update on the management of gonorrhea in adults in the United States.","volume":"44","author":"Newman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1808.111202-201307151429-R13","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1128\/AAC.01604-06","article-title":"Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.","volume":"51","author":"Lindberg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1808.111202-201307151429-R14","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.37.19330-en","article-title":"Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands.","volume":"14","author":"de Vries","year":"2009","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid1808.111202-201307151429-R15","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jama.1990.03450110059027","article-title":"National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.","volume":"264","author":"Schwarcz","year":"1990","journal-title":"JAMA"},{"key":"key-10.3201\/eid1808.111202-201307151429-R16","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 2010. Wayne (PA): The Institute; 2010."},{"key":"key-10.3201\/eid1808.111202-201307151429-R17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0966-842X(01)02130-8","article-title":"The rise and fall of antimicrobial resistance.","volume":"9","author":"Lipsitch","year":"2001","journal-title":"Trends Microbiol"},{"key":"key-10.3201\/eid1808.111202-201307151429-R18","doi-asserted-by":"crossref","unstructured":"Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. Hoboken (NJ): Wiley; 2002. p. xv.","DOI":"10.1002\/9781119013563"},{"key":"key-10.3201\/eid1808.111202-201307151429-R19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1503\/cmaj.081721","article-title":"Multidrug-resistant Neisseria gonorrhoeae.","volume":"180","author":"Tapsall","year":"2009","journal-title":"CMAJ"},{"key":"key-10.3201\/eid1808.111202-201307151429-R20","unstructured":"Health Protection Agency. The Gonococcal Resistance to Antimicrobials Surveillance Programme: annual report, 2007 [cited 2012 May 22]. http:\/\/www.hpa.org.uk\/web\/HPAwebFile\/HPAweb_C\/1221117895841"},{"key":"key-10.3201\/eid1808.111202-201307151429-R21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1086\/444429","article-title":"Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London.","volume":"192","author":"Martin","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1808.111202-201307151429-R22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2148-7-84","article-title":"Distinguishing importation from diversification of quinolone-resistant Neisseria gonorrhoeae by molecular evolutionary analysis.","volume":"7","author":"P\u00e9rez-Losada","year":"2007","journal-title":"BMC Evol Biol"},{"key":"key-10.3201\/eid1808.111202-201307151429-R23","unstructured":"Centers for Disease Control and Prevention. GISP profiles, 2009. [cited 2012 May 22]. http:\/\/www.cdc.gov\/std\/gisp2009\/default.htm"},{"key":"key-10.3201\/eid1808.111202-201307151429-R24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.amjmed.2004.09.015","article-title":"Fluoroquinolone prescribing in the United States: 1995 to 2002.","volume":"118","author":"Linder","year":"2005","journal-title":"Am J Med"},{"key":"key-10.3201\/eid1808.111202-201307151429-R25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1086\/430704","article-title":"Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.","volume":"41","author":"Kent","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1808.111202-201307151429-R26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijantimicag.2005.08.021","article-title":"Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.","volume":"27","author":"Tanaka","year":"2006","journal-title":"Int J Antimicrob Agents"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/18\/8\/11-1202_intro","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:15:30Z","timestamp":1733285730000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/18\/8\/11-1202_intro.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1808.111202","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}